BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16449337)

  • 1. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance.
    Charmandari E; Kino T; Ichijo T; Zachman K; Alatsatianos A; Chrousos GP
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1535-43. PubMed ID: 16449337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
    Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.
    Charmandari E; Kino T; Ichijo T; Jubiz W; Mejia L; Zachman K; Chrousos GP
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3986-90. PubMed ID: 17635946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.
    Charmandari E; Ichijo T; Jubiz W; Baid S; Zachman K; Chrousos GP; Kino T
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4963-8. PubMed ID: 18827003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.
    Charmandari E; Kino T; Souvatzoglou E; Vottero A; Bhattacharyya N; Chrousos GP
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1939-49. PubMed ID: 15070967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of the hGRαT556I causing Chrousos syndrome.
    Nicolaides NC; Skyrla E; Vlachakis D; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
    Eur J Clin Invest; 2016 Jan; 46(1):42-9. PubMed ID: 26541474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
    Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
    Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.
    Roberts ML; Kino T; Nicolaides NC; Hurt DE; Katsantoni E; Sertedaki A; Komianou F; Kassiou K; Chrousos GP; Charmandari E
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E790-5. PubMed ID: 23426617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
    Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes.
    Charmandari E; Chrousos GP; Ichijo T; Bhattacharyya N; Vottero A; Souvatzoglou E; Kino T
    Mol Endocrinol; 2005 Jan; 19(1):52-64. PubMed ID: 15459252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identification and characterization of a and b forms of the glucocorticoid receptor.
    Yudt MR; Cidlowski JA
    Mol Endocrinol; 2001 Jul; 15(7):1093-103. PubMed ID: 11435610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells.
    Jewell CM; Scoltock AB; Hamel BL; Yudt MR; Cidlowski JA
    Mol Endocrinol; 2012 Feb; 26(2):244-56. PubMed ID: 22174376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptor phosphorylation modulates transcription efficacy through GRIP-1 recruitment.
    Avenant C; Kotitschke A; Hapgood JP
    Biochemistry; 2010 Feb; 49(5):972-85. PubMed ID: 20047289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation of the hGR gene causing Chrousos syndrome.
    Nicolaides NC; Geer EB; Vlachakis D; Roberts ML; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
    Eur J Clin Invest; 2015 Aug; 45(8):782-91. PubMed ID: 26031419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors.
    Jewell CM; Webster JC; Burnstein KL; Sar M; Bodwell JE; Cidlowski JA
    J Steroid Biochem Mol Biol; 1995 Nov; 55(2):135-46. PubMed ID: 7495692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action.
    Oakley RH; Jewell CM; Yudt MR; Bofetiado DM; Cidlowski JA
    J Biol Chem; 1999 Sep; 274(39):27857-66. PubMed ID: 10488132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human glucocorticoid receptor alpha transcript splice variants with exon 2 deletions: evidence for tissue- and cell type-specific functions.
    Geng CD; Pedersen KB; Nunez BS; Vedeckis WV
    Biochemistry; 2005 May; 44(20):7395-405. PubMed ID: 15895983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.
    Nicolaides NC; Roberts ML; Kino T; Braatvedt G; Hurt DE; Katsantoni E; Sertedaki A; Chrousos GP; Charmandari E
    J Clin Endocrinol Metab; 2014 May; 99(5):E902-7. PubMed ID: 24483153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants.
    de Lange P; Koper JW; Huizenga NA; Brinkmann AO; de Jong FH; Karl M; Chrousos GP; Lamberts SW
    Mol Endocrinol; 1997 Jul; 11(8):1156-64. PubMed ID: 9212062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.